Barry Keith Herman MD MMM (He/Him)

PubMed

• 2 citations
  Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults:
  Barry K. Herman, Mohammed Bouhajib, Thomas R. King, Judith C. Kando, Antonio Pardo
  Journal of Attention Disorders. 2021-04-01
• 1 citations
  Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension.
  Antonio Pardo, Judith C. Kando, Thomas R. King, Eman Rafla, Barry K. Herman
  CNS Spectrums. 2020-01-22
• 6 citations
  Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
  Ann C. Childress, Judith C. Kando, Thomas R. King, Antonio Pardo, Barry K. Herman
  Journal of Child and Adolescent Psychopharmacology. 2019-01-25

Journal Articles

• Communication between Physicians and Patients with Suspected or Diagnosed Binge Eating Disorder  
  Kornstein, SG, Keck Jr., PE, Herman, BK, Puhl, RM, Wilfley, DE, DiMarco ID, Postgraduate Medicine, 1/1/2015
• The Psychological and Medical Factors Associated With Untreated Binge Eating Disorder  
  Sheehan DV, Herman BK, Prim Care Companion CNS Disord, 1/1/2015
• The Patient Experience with DSM-5-defined Binge Eating Disorder: Characteristics, Barriers to Treatment and Implications for Primary Care Physicians  
  Herman, BK, Safikhani, S, Hengerer, D, Atkins, N, Kim, A, Cassidy, D, Babcock, T, Agus, S, Lenderking, W., Postgraduate Medicine, 1/1/2014
• The Year in Review: The American Association of Psychiatric Administrators  
  Herman, BK, Journal of Psychiatric Administration and Management, 1/1/2013
• Ziprasidone in Black Patients with Schizophrenia: Analysis of Four Short-term, Double Blind Studies  
  Lawson, WB, Herman, BK, Loebel, A, Lazariciu, I, and Malik, M, CNS Spectr, 1/1/2009
• Long-term Safety and Tolerability of Pregabalin Treatment in Three Open-label Extension Studies in Patients with Fibromyalgia  
  Murphy, K, Zeiher, B, Herman, B, Atkinson, G, Pauer, L, Whelan, L, Journal of Pain, 1/1/2009
• Pregabalin Treatment Improves Fatigue, Function and Self-reported Presenteeism in Fi  
  Murphy, K, Pauer, L, Clauw, D, Herman, B, Ikeda, L, Atkinson, G, Zeiher. B, Journal of Pain, 1/1/2009
• Efficacy of Pregabalin and Venlafaxine-XR in Generalized Anxiety Disorder: Results of a Double-blind, Placebo-controlled 8-week Trial  
  Kasper, S, Herman, B, Nivoli, G, Van Ameringen, M, Petralia, A, Mandel, F, Baldinetti, F, and Bandelow, B., Int Clin Psychopharmacol, 1/1/2009
• Managing Up: Dynamic following in an Organizational Setting  
  Herman, BK, Psychiatrist Administrator, 1/1/2007
• Comments on "Presidential Address: Advocacy as Leadership"  
  Clary C, Loebel A, Lombardo I, Alphs L, Binneman B, Vanderburg D, Warrington L, Parsons B, Fogel I, Herman B, Roberts H, Templeton H, Hughes D, Chappell P, Feltner D, ..., Am J Psychiatry, 1/1/2007
• Comments on "Dose Response and Dose Equivalence of Antipsychotics"  
  Walker JK, Herman BK, Loebel A, J Clin Psychopharmacol, 1/1/2005
• Comments on "Dose Response and Dose Equivalence of Antipsychotics"  
  Walker JK, Herman BK, Loebel A, JClinPsych, 1/1/2004
• Treating the Mentally Ill  
  Peele R, Kline L, Herman B, Health Aff (Millwood), 1/1/2001
• Another Way to Regain Control  
  Herman BK, Tex Med, 1/1/1998
• Triazolam Used to Treat Jet Lag: Dose and Direction Effects in a Questionnaire Study  
  Seidel WF, Cohen SA, Bliwise NG, Herman B, Dement WC, Sleep Research, 1/1/1987
• An Overlooked Group: Giving Pharmaceutical Doc-execs Their Due Respect  
  Lazarus, A, Herman B, Modern Physician, 1/9./2006
• Comparative Efficacy of Pregabalin and Benzodiazepines in Treating the Psychic and Somatic Symptoms of Generalized Anxiety Disorder  
  Lydiard RB, Rickels K, Herman B, Feltner DE., Int J Neuropsychopharmacol, 1/9./2009
• Special Report: Practice Management  
  Psychiatric Times, 1/7./2010
• Validation of the Yale-brown Obsessive Compulsive Scale Modified for Binge Eating  
  Deal LS, Wirth RJ, Gasior M, Herman BK, McElroy SL., Int J Eat Disord, 1/1./2015
• Join now to see all

Books/Book Chapters

• Privacy: Opposing Viewpoints Series 
  Chapter: Federal Law Violates Patients' Privacy 
  Page 141.0 - 148.0Herman, Barry K. and Peel, Deborah C.Editors: Carroll, Jamuna.Thompson Gale, MI2006
• Master Clinicians on Treating the Regressed Patient. 
  Chapter: Preface 
  Herman BKEditors: Boyer, L. Bryce & Giovacchini, Peter L..Jason Aronson, Northvale, NJ1993

Abstracts/Posters

• Partnering with the Pharmaceutical Industry
  Herman, BK, Fegert, JM, Baron, D., Turkish Journal of Psychiatry, 1/1/2006
• Ziprasidone vs Haloperidol for the Treatment of Agitation
  Citrome, L, Brook, S, Herman, BK, Loebel, A, Mandel, F, American Psychiatric Association Annual Meeting, Atlanta, GA, 1/1/2005
• Ziprasidone vs Haloperidol for the Treatment of Agitation
  Citrome, L, Brook, S, Herman, BK, Loebel, A, Mandel, F, Society for Biological Psychiatry, Atlanta, GA, 1/1/2005
• Ziprasidone in Hospitalized Patients with Schizophrenia: Evidence for Rapid Dose Titration
  Vanderburg, D, Loebel, A, Warrington, L, Herman, B, Yang, R., 11th International Congress on Schizophrenia Research, Colorado Springs, CO, 1/28/2007
• Efficacy of Pregabalin and Venlafaxine-XR in Generalized Anxiety Disorder: Results of a Double-Blind, Placebo-Controlled 8-Week Trial
  Herman, B, Nivoli, G, Petralia, A, Mandel, F., XXVI Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Munich, Germany, 1/13/2008
• Functional and Quality of Life Impairment in Generalized Anxiety Disorder: Effect of Short-Term Treatment With Pregabalin and Venlafaxine-XR
  Mychaskiw, M, Alvir, J, Herman, B., XXVI Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Munich, Germany, 1/13/2008
• Insomnia and Generalized Anxiety Disorder: Impact on Clinical Presentation and Response to Pregabalin
  Pallanti, S, Giordano, S, Mandel, F, Herman, B., 16th AEP European Congress of Psychiatry, Nice, France, 1/5./2008
• Pregabalin Improves Pain in Fibromyalgia (FM) Patients Regardless of Baseline Anxiety and Depression Levels
  Leon, T, Whalen, E, Arnold, L, Pauer, L, Barrett, J, Herman, B., 16th AEP European Congress of Psychiatry, Nice, France, 1/5./2008
• Rapid Onset Anxiolytic Efficacy After a Single Dose of Pregabalin: Double-Blind, Placebo-Controlled Evaluation Using a Dental Anxiety Model
  Murphy, T, Nutt, D, Mandel, F, Herman, B., 16th AEP European Congress of Psychiatry, Nice, France, 1/5./2008
• Efficacy of Pregabalin Monotherapy for Improving Sleep Outcomes in Patients With Fibromyalgia: Results of a 14-Week, Double-Blind, Placebo-Controlled Trial (RELIEF Study)
  Leon, T, Pauer, L, Whalen, E, Herman, B, Barrett, J., 16th AEP European Congress of Psychiatry, Nice, France, 1/5./2008
• Efficacy of Pregabalin and Venlafaxine-XR in Generalized Anxiety Disorder: Results of a Double-Blind, Placebo-Controlled 8-Week Trial
  Andreewitch, S, Murphy, T, Petralia, A, Mandel, F, Herman, B., 16th AEP European Congress of Psychiatry, Nice, France, 1/5./2008
• Efficacy of Ziprasidone in Hospitalized Manic Patients With High Baseline Symptom Severity
  Allen, M, Vanderburg, D, Loebel, T, Herman, B, Mandel, F., 59th Institute on Psychiatric Services, New Orleans, Louisiana, 1/11/2007
• The Influence of Meal Size and Fat Content on Oral Ziprasidone Bioavailability
  Gandelman, K, Miceli, J. Alderman, J., Glue, P, Versavel, M, Lombardo, I, Wilner, K, Herman, B, Preskorn, S., 7th International Congress on Bipolar Disorder, Pittsburgh, PA, 1/7./2007
• Effect of Regression to the Mean on the Assessment of Antipsychotic-Induced Weight Gain
  Loebel, A, Lombardo, I, Siu, C, Allison, D, Herman, B., Society of Biological Psychiatry, San Diego, CA, 1/18/2007
• Psychic and Somatic Anxiety Symptom Burden and Functional Remission in Generalized Anxiety Disorder
  Mychaskiw, M, Hoffman, D, Dodge, W, Herman, B., European Congress of Neuropsychopharmacology, Barcelona, Spain, 1/30/2008
• Long-term Efficacy of Ziprasidone in Treatment-Resistant Schizophrenia: Results From the 1-Year, Open-Label MOZART Extension Study
  Herman BK, 11th International Congress on Schizophrenia Research, Colorado Springs, CO, 1/28/2007
• Risk for Diabetes and Coronary Heart Disease: Effects of Metabolic Changes in Phase 1 of the CATIE Study
  Herman, B, Sorensen, S, Cuffel, B, Lombardo, I, Revicki, D., US Psychiatric Congress, New Orleans, LA, 1/15/2006
• Risk for Diabetes and Coronary Heart Disease: Effects of Metabolic Changes in Phase 1 of the CATIE Study
  Cuffel, B, Lombardo, I, Nasrallah, H, Herman, B, Sorensen, S, Revicki, D., 58th Institute on Psychiatric Services, New York, NY, 1/5./2006
• Comparative Efficacy and Safety of Ziprasidone and Clozapine in Treatment-Refractory Schizophrenia: Results of a Randomized, Double-Blind, 18-Week Trial
  Sacchetti, E, Galluzzo, A, Valsecchi, P, Romeo, F, Gorini, P, Herman, B, Warrington, L., 58th Institute on Psychiatric Services, New York, NY, 1/5./2006
• Comparative Effects of Ziprasidone and Olanzapine on Markers of Insulin Resistance: Results of a 6-week Randomized Study in Patients with Acute Schizophrenia
  Meyer, J, Loebel, A, Herman, B, Nasrallah, H, New Clinical Drug Evaluation Unit (NCDEU), Boca Raton, 1/13/2006
• Course of Weight and Metabolic Benefits 1 Year after Switching to Ziprasidone
  Weiden, PJ, Herman, BK, Yang, R, Lebovitz, H, U.S. Psychiatric Congress, San Diego, 1/17/2004
• Binge Eating Disorder Patient Characteristics and Barriers to Treatment: A Qualitative Study
  Herman, BK, Safkhani, S, Hengerer, D, Atkins, N, Kim, A, Cassidy, D, Babcock, T, Lenderking, WR, APA Annual Meeting, New York, NY, 1/6./2014
• Time Course of the Effects of Lisdexamfetamine Dimesylate in Two Phase 3 Randomized, Double-blind, Placebo-controlled Trials in Adults with Binge Eating Disorder
  McElroy, S, Hudson, J, Gasior, M, Herman, B, Radewonuk, J, Wilfley, D, Busner, J, American Society of Clinical Psychopharmacology Annual Meeting, Miami Beach, FL, 1/22/2015
• Effects of Lisdexamfetamine Dimesylate on Functional Impairment on the Sheehan Disability Scale in Adults with Moderate to Severe Binge Eating Disorder: Results from ...
  Sheehan, D, Gasior, M, McElroy, S, Radewonuk, J, Herman, B, Pawaskar, M, Hudson, J., American Society of Clinical Psychopharmacology Annual Meeting, Miami Beach, FL, 1/22/2015
• Development of the Binge-Eating Disorder Screener
  Herman B, Deal L, DiBenedetti D, Nelson L, Fehnel S, Brown TM., American Psychiatric Association (APA) Annual Meeting, Toronto, Canada, 1/16/2015
• Join now to see all